These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6860533)

  • 1. Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.
    Birkett DJ; Miners JO; Attwood J
    Br J Clin Pharmacol; 1983 May; 15(5):567-9. PubMed ID: 6860533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol.
    Staiger C; Schlicht F; Walter E; Gundert-Remy U; Hildebrandt R; de Vries J; Wang NS; Harenberg J; Weber E
    Eur J Clin Pharmacol; 1983; 25(6):797-801. PubMed ID: 6141054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):321-6. PubMed ID: 7106168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline-rifampicin interaction: non-selective induction of theophylline metabolic pathways.
    Robson RA; Miners JO; Wing LM; Birkett DJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):445-8. PubMed ID: 6487483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of sulphinpyrazone with warfarin.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):327-31. PubMed ID: 7106169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cimetidine, sulfinpyrazone, and cigarette smoking on theobromine metabolism in man.
    Miners JO; Attwood J; Wing LM; Birkett DJ
    Drug Metab Dispos; 1985; 13(5):598-601. PubMed ID: 2865110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal clearance of sulphinpyrazone in man.
    Lentjes EG; Russel FG; van Ginneken CA
    Eur J Clin Pharmacol; 1986; 31(4):473-8. PubMed ID: 3816927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic drug interactions with theophylline.
    Jonkman JH; Upton RA
    Clin Pharmacokinet; 1984; 9(4):309-34. PubMed ID: 6147220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves.
    Girolami A; Fabris F; Casonato A; Randi ML
    Clin Lab Haematol; 1982; 4(1):23-6. PubMed ID: 7067372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of theophylline and theobromine metabolism in man.
    Birkett DJ; Dahlqvist R; Miners JO; Lelo A; Billing B
    Drug Metab Dispos; 1985; 13(6):725-8. PubMed ID: 2867879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
    Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
    J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cimetidine on theophylline metabolic pathways.
    Grygiel JJ; Miners JO; Drew R; Birkett DJ
    Eur J Clin Pharmacol; 1984; 26(3):335-40. PubMed ID: 6734695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity and dose-dependency of the inhibitory effect of propranolol on theophylline metabolism in man.
    Miners JO; Wing LM; Lillywhite KJ; Robson RA
    Br J Clin Pharmacol; 1985 Sep; 20(3):219-23. PubMed ID: 4041342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The warfarin-sulfinpyrazone interaction: stereochemical considerations.
    Toon S; Low LK; Gibaldi M; Trager WF; O'Reilly RA; Motley CH; Goulart DA
    Clin Pharmacol Ther; 1986 Jan; 39(1):15-24. PubMed ID: 3943265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil disposition--effects of sulphinpyrazone and cimetidine.
    Wing LM; Miners JO; Lillywhite KJ
    Br J Clin Pharmacol; 1985 Mar; 19(3):385-91. PubMed ID: 3986090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphinpyrazone and warfarin: a probable drug interaction.
    Gallus A; Birkett D
    Lancet; 1980 Mar; 1(8167):535-6. PubMed ID: 6102248
    [No Abstract]   [Full Text] [Related]  

  • 17. Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
    Dahlqvist R; Bertilsson L; Birkett DJ; Eichelbaum M; Säwe J; Sjöqvist F
    Clin Pharmacol Ther; 1984 Jun; 35(6):815-21. PubMed ID: 6734034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatment.
    Schlicht F; Staiger C; de Vries J; Gundert-Remy U; Hildebrandt R; Harenberg J; Wang NS; Weber E
    Eur J Clin Pharmacol; 1985; 28(1):97-103. PubMed ID: 3987792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphinpyrazone metabolism during long-term therapy.
    Pedersen AK; Jakobsen P
    Br J Clin Pharmacol; 1981 Jun; 11(6):597-603. PubMed ID: 7272176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition.
    Robson RA; Miners JO; Whitehead AG; Birkett DJ
    Br J Clin Pharmacol; 1987 Jun; 23(6):772-5. PubMed ID: 3606937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.